Quinoline-based compounds and methods of inhibiting cdk8/19
AssigneesUniversity of South Carolina, Senex Biotechnology, Inc.
InventorsIgor Roninson, Campbell McInnes, Mengqian Chen, Li Zhang, Jing Li
Life of this patent
Estimating the term…
Loading patent…
AssigneesUniversity of South Carolina, Senex Biotechnology, Inc.
InventorsIgor Roninson, Campbell McInnes, Mengqian Chen, Li Zhang, Jing Li
Estimating the term…
Disclosed herein are quinoline-based compounds and method for inhibiting CDK8 or CDK19 for the intervention in diseases, disorders, and conditions. The quinoline-based composition comprise substituents at quinoline ring positions 4 and 6, wherein the substituent at position 4 is selected from a substituted or unsubstituted arylalkylamine or a substituted or unsubstituted arylhetrocyclylamine. Pharmaceutical compositions comprising the substituted qunioline compositions, methods of inhibiting CDK8 or CDK19, and methods of treating CDK8/19-associated diseases, disorders, or conditions are also disclosed.
A compound of Formula 1B
Dependencies are inferred from the claim text.